ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.

Acquired Companies: Prevalere Life Sciences, Inc., Healthcare Discoveries, Inc., Qualia Clinical Services